Fresenius SE & Co. KGaA (FRA:FRE) received a €70.00 ($82.35) price target from equities researchers at HSBC Holdings PLC in a report issued on Wednesday. The brokerage presently has a “neutral” rating on the stock. HSBC Holdings PLC’s price target would suggest a potential upside of 13.93% from the company’s previous close.

Other equities research analysts have also recently issued reports about the stock. Berenberg Bank set a €90.00 ($105.88) price target on shares of Fresenius SE & Co. KGaA and gave the company a “buy” rating in a report on Wednesday, August 2nd. Independent Research GmbH set a €94.00 ($110.59) price target on shares of Fresenius SE & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, August 1st. S&P Global set a €85.00 ($100.00) price target on shares of Fresenius SE & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, August 1st. Commerzbank Ag set a €86.00 ($101.18) price target on shares of Fresenius SE & Co. KGaA and gave the company a “buy” rating in a report on Tuesday, August 1st. Finally, Deutsche Bank AG set a €85.00 ($100.00) price target on shares of Fresenius SE & Co. KGaA and gave the company a “buy” rating in a report on Wednesday, August 2nd. Seven equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of €80.41 ($94.60).

Shares of Fresenius SE & Co. KGaA (FRA:FRE) opened at €61.44 ($72.28) on Wednesday. Fresenius SE & Co. KGaA has a fifty-two week low of €61.16 ($71.95) and a fifty-two week high of €80.00 ($94.12).

ILLEGAL ACTIVITY NOTICE: This piece of content was first published by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another publication, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.watchlistnews.com/fresenius-se-70-00-by-hsbc-holdings-plc/1722838.html.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Analyst Recommendations for Fresenius SE & Co. KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with Analyst Ratings Network's FREE daily email newsletter.